SAN DIEGO, June 29, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that the company applauds Oklahoma voters for legalizing medical marijuana in their state.
“The support and education surrounding cannabis in the U.S. is growing exponentially and we’re excited to see yet another state commit to providing its residents with access to this therapeutic plant,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “This vote is especially monumental because of the state’s historically-conservative stance and we look forward to more states on both sides of the political spectrum following suit in the near future.”
The new regulation will legalize the use, sale and growth of medical marijuana in Oklahoma. It requires a medical marijuana license with approval from an Oklahoma board-certified physician. It also establishes a minimum age of 18 for medical marijuana licenses, although younger applicants can receive an exception if a legal guardian and two doctors sign.
Medical Marijuana, Inc. sells hemp-derived cannabidiol (CBD) products through its distribution subsidiaries HempMeds®, Kannaway® and Phyto Animal Health. These products range from tinctures and liquids to topicals and edibles. The company was the first company to ever bring hemp-based CBD oil products to market in the U.S. in 2012 and the first to receive federal government import approvals in Mexico, Paraguay, Argentina and Brazil.
According to the National Conference of State Legislatures, medical marijuana is now legal in some form in 30 states. Nine states and Washington, D.C. allow for recreational use and sales.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer CMW Media